A Umbricht

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Naltrexone shortened opioid detoxification with buprenorphine
    A Umbricht
    NIDA Intramural Research Program, Addiction Research Center, Baltimore, MD, USA
    Drug Alcohol Depend 56:181-90. 1999
  2. ncbi request reprint Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing
    M A Huestis
    Chemistry and Drug Metabolism Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland 21224, USA
    J Anal Toxicol 24:509-21. 2000
  3. ncbi request reprint Family history influence on drug abuse severity and treatment outcome
    R W Pickens
    Clinical Neurogenetics Section and Treatment Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA
    Drug Alcohol Depend 61:261-70. 2001
  4. pmc Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans
    M A Huestis
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA
    Drug Alcohol Depend 131:258-62. 2013
  5. ncbi request reprint Therapeutic drug monitoring in methadone maintenance: choosing a matrix
    E T Moolchan
    Department of Health and Human Services, National Institute of Health, National Institute of Drug Abuse, Baltimore, MD 21224, USA
    J Addict Dis 20:55-73. 2001
  6. ncbi request reprint Shaping cocaine abstinence by successive approximation
    K L Preston
    Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland 21224, USA
    J Consult Clin Psychol 69:643-54. 2001
  7. ncbi request reprint Cyclazocine: comparison to hydromorphone and interaction with cocaine
    K L Preston
    National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, USA
    Behav Pharmacol 15:91-102. 2004

Detail Information

Publications7

  1. ncbi request reprint Naltrexone shortened opioid detoxification with buprenorphine
    A Umbricht
    NIDA Intramural Research Program, Addiction Research Center, Baltimore, MD, USA
    Drug Alcohol Depend 56:181-90. 1999
    ..Peak withdrawal symptoms after naltrexone were of moderate intensity, suggesting that naltrexone combined with buprenorphine is an acceptable and safe treatment for shortened opioid detoxification and induction of naltrexone maintenance...
  2. ncbi request reprint Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing
    M A Huestis
    Chemistry and Drug Metabolism Section, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland 21224, USA
    J Anal Toxicol 24:509-21. 2000
    ..However, the percentage of false-negative results, at least in this treatment population, indicates that weekly sweat testing may be less sensitive than thrice weekly urine testing in detecting opiate use...
  3. ncbi request reprint Family history influence on drug abuse severity and treatment outcome
    R W Pickens
    Clinical Neurogenetics Section and Treatment Research Branch, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA
    Drug Alcohol Depend 61:261-70. 2001
    ..Both effects remained significant after adjusting for gender and race. These results suggest that common genetic factors may underlie both susceptibility to heroin dependence and response to therapeutic methadone treatment...
  4. pmc Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans
    M A Huestis
    Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA
    Drug Alcohol Depend 131:258-62. 2013
    ..Prescribed sublingual (SL) buprenorphine is sometimes diverted for intravenous (IV) abuse, but no human pharmacokinetic data are available following high-dose IV buprenorphine...
  5. ncbi request reprint Therapeutic drug monitoring in methadone maintenance: choosing a matrix
    E T Moolchan
    Department of Health and Human Services, National Institute of Health, National Institute of Drug Abuse, Baltimore, MD 21224, USA
    J Addict Dis 20:55-73. 2001
    ..However, saliva methadone concentrations are influenced by salivary pH, and future studies are needed to determine how to control for that. Administrative, medical, and social implications of methadone TDM are briefly discussed...
  6. ncbi request reprint Shaping cocaine abstinence by successive approximation
    K L Preston
    Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland 21224, USA
    J Consult Clin Psychol 69:643-54. 2001
    ..A 2nd phase of the study showed that abstinence induced by escalating-value vouchers can be maintained by a nonescalating schedule, suggesting that contingency management can be practical as a maintenance treatment...
  7. ncbi request reprint Cyclazocine: comparison to hydromorphone and interaction with cocaine
    K L Preston
    National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, USA
    Behav Pharmacol 15:91-102. 2004
    ..This study is suggestive but not strongly supportive for the use of kappa-opiate drugs to diminish acute effects of cocaine administration or for the use of these kappa agonists in drug abuse treatment applications...